| Schedule of Segment Reporting Information |
The following table presents the measure of segment assets regularly provided to the CODM (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
Cash, cash equivalents and short-term investments |
|
|
18,163 |
|
|
|
17,752 |
|
The following table presents financial information, including significant segment expenses, which are regularly provided to the CODM and included within condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2026 |
|
|
2025 |
|
Research and development: |
|
|
|
|
|
|
Personnel |
|
$ |
1,914 |
|
|
$ |
1,320 |
|
Stock-based compensation |
|
|
542 |
|
|
|
435 |
|
Clinical and contract manufacturing |
|
|
3,600 |
|
|
|
6,727 |
|
Other |
|
|
789 |
|
|
|
(337 |
) |
General and administrative: |
|
|
|
|
|
|
Personnel |
|
|
1,335 |
|
|
|
1,727 |
|
Stock-based compensation |
|
|
744 |
|
|
|
951 |
|
Consulting and professional costs |
|
|
1,558 |
|
|
|
1,466 |
|
Other |
|
|
630 |
|
|
|
645 |
|
Intangible asset impairment charge |
|
|
67,808 |
|
|
|
— |
|
Fair value adjustment for contingent consideration |
|
|
(64,330 |
) |
|
|
1,924 |
|
Total operating expenses |
|
|
14,590 |
|
|
|
14,858 |
|
Loss from operations |
|
|
(14,590 |
) |
|
|
(14,858 |
) |
Fair value adjustment for debt |
|
|
12,168 |
|
|
|
(444 |
) |
Fair value adjustment for warrants |
|
|
31,116 |
|
|
|
— |
|
Other segment items |
|
|
7,218 |
|
|
|
272 |
|
Net income (loss) |
|
$ |
35,912 |
|
|
$ |
(15,030 |
) |
|